Lineage commitment during Embryonic Stem Cells (ESCs) differentiation is controlled not only by a gamut of transcription factors but also by epigenetic events, mainly histone deacetylation and promoter DNA methylation. Moreover, the DNA demethylation agent 5-Aza-2-deoxycytidine (AzadC) has been widely described in the literature as an effective chemical stimulus used to promote cardiomyogenic differentiation in various stem cell types; however, its toxicity and instability complicate its use. Thus, the purpose of this study was to examine the effects of zebularine, a stable and non-toxic DNA cytosine methylation inhibitor, on ESCs differentiation. Herein are the Affymetrix Expression data obtained from RNA of murine ESCs treated with zebularine.
Zebularine regulates early stages of mESC differentiation: effect on cardiac commitment.
Specimen part, Cell line, Treatment
View SamplesThis SuperSeries is composed of the SubSeries listed below.
LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus.
Age, Specimen part, Treatment
View SamplesStrategy to repress autoimmunity and promote islet beta cell regeneration
LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus.
Age, Specimen part, Treatment
View Samples